Immunosuppression of direct T-cell-mediated xenorecognition in vitro.
Imperial College of Science Technology and Medicine, London, UK.
N J
NJ
Rogers
V
V
Mirenda
I
I
Jackson
A
A
Dorling
R I
RI
Lechler
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D000943:Antigens, Differentiation / Q000276:immunology; D051940:B7-2 Antigen; D060908:CTLA-4 Antigen; D002460:Cell Line; D004730:Endothelium, Vascular / Q000276:immunology*; D007111:Immunity, Cellular; D018796:Immunoconjugates; D008213:Lymphocyte Activation / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D013045:Species Specificity; D013552:Swine; D013601:T-Lymphocytes / Q000276:immunology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D051940:B7-2 Antigen; D060908:CTLA-4 Antigen; C497965:Cd86 protein, mouse; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D008562:Membrane Glycoproteins; D000069594:Abatacept